Biotech Business Week

Hepatitis C Therapy - Data reported from phase IB trial of Isatoribine

Alzheimer Disease - Alzheimer disease treatment slows progression of cognitive decline in study

Genitourinary Disorders - Patents acquired for development of genitourinary disorder treatments

Genomics - Genaissance enters into HAP Technology license agreement

Genomics - Human Genome Sciences announces license agreement

Genomics R&D - New genomics screening platform technology developed

Genomics Research - New business venture formed to commercialize microparticle technology

HIV Therapy - 48-Week data submitted to FDA for full approval of HIV fusion inhibitor

Hepatitis C Virus - Investigational drug, merimepodib, well tolerated in hepatitis C clinical trial

Hepatitis Virus - Biotechnology company increases production capacity of liver treatment

Hepatotoxicity - Collaboration signed with AstraZeneca focused on predictive toxicity

Immunoactivity - Peyote cactus extract can activate NO, increase cytokines, kill tumor cells

Alzheimer Disease - Scope of Phenserine trial; sub-study to include brain scans

Immunodeficiency Disease - FDA license granted for intravenous immunoglobulin

Infection Control - Program designed to help hospitals, physicians slow spread of flu, SARS

Influenza - Health plan provider expands coverage to include intranasal flu vaccines

Influenza - Plan expands coverage to nasal flu vaccine

Influenza A - Hand sanitizer provides greater than 99% kill against influenza A in studies

Information Technology - Study examines impact of clinical guideline messaging at point of care

Joint Replacement - FDA clears Palacos G antibiotic-loaded bone cement

Legal Issues - Lumenis litigation settled

Lung Cancer - Cancer drug development status reported

Lung Cancer - Neovastat's clinical development plan updated

Anticancer Drugs - Phase I clinical trial for encapsulated anticancer drug delayed until third quarter 2004

Magnetic Resonance Imaging - Nanomagnetic particles used as contrast agent improves detail

Malignant Pleural Effusion - FDA grants approval of Sterile Talc Powder

Market Analysis - 2003 was biotech's second best year with market cap up 32%

Market Analysis - Report reveals how companies optimize biomarker research

Market Analysis - Survey says reduced leisure time activities may contribute to obesity

Market Trends - Report forecasts more device-based interventions for prostate disease

Marketing Trends - Launching blockbuster drugs: Marketing budgets push drugs to success

Memory Improvement - Concord grape juice improved memory, neuromotor skills in animal study

Mergers and Acquisitions - Acquisition to advance treatment of viral diseases and neurological disorders

Mergers and Acquisitions - Agreement signed to acquire biopharmaceutical distribution subsidiary of Roche

Antisense Technology - Molecula receives license to key RNAi patent

Mergers and Acquisitions - Clinomics Biosciences in agreement to be acquired

Mergers and Acquisitions - Diagnostics company acquires assets of imaging developer

Mergers and Acquisitions - Intermagnetics agrees to acquire patient monitoring company for $22/share

Mergers and Acquisitions - Oral fluid diagnostics company sells laboratory subsidiary

Mergers and Acquisitions - Point-of-care diagnostics company acquired by pharmaceutical firm

Mergers and Acquisitions - Recently acquired San Diego operations closed by oncology firm

Metastatic Cancer - Oncolytic vector technology licensed for development of cancer therapy

Microarray Technology - New microarray hybridization chamber launched

Microarray Technology - New technology to help development of medical and diagnostic antibodies

Nanotechnology - NanoBio forms company to commercialize drug-delivery and imaging technology

Arthritis - FDA grants approval for Indomethacin capsules

Nerve Dysfunction - Device company's neurotechnology improves foot sensation in diabetics

Non-Hodgkin Lymphoma - Trial yields positive results for Rituxan plus CVP chemotherapy

Obesity Management - FDA approves labeling for use of Xenical in adolescent patients

Obesity Therapy - Nutrient selected for study of gastric bypass surgery patients

Oncology - NaPro completes sale of worldwide paclitaxel business

Patents - European regulatory authorities revoke patent related to Cellegesic

Patents - Micro-electro-mechanical systems patent granted on multi-target chip technology

Patents - New adenoviral vector technology wins patent; Introgen gets license

Patents - Oncolytic viral technology licensed to Introgen Therapeutics

Personnel - Biotech company brings business development veteran on board

Asthma - Second phase II study initiated to evaluate Corus 1030

Personnel - Butz named VP of global regulatory affairs at drug discovery firm

Personnel - CNS-focused biopharmaceutical company announces new vice president

Personnel - Cardiovascular/metabolic disease-focused company opens representative office in Japan

Personnel - Davenport named CEO at medical device company

Personnel - Davenport named VP, business development at drug delivery firm

Personnel - Drug development company appoints new chief financial officer

Personnel - Executive director of medical affairs appointed at pharmaceutical firm

Personnel - Garrett named president, chief operating officer at biomedical company

Personnel - Medical device manufacturer names new VP of regulatory and clinical affairs

Personnel - Microarray technology company broadens scientific advisory board

Atrial Flutter - U.S. pivotal trial begins for cardiac cryoblation system

Personnel - Peptidomics company names new chief scientific officer

Pharmaceutical Manufacturing - Genentech inks Rituxan manufacturing agreement

Pharmaceutical Marketing - Frequent sales force realignments drag down long-term effectiveness

Pregnancy Test - Inverness to supply Pfizer with a digital version of its e.p.t pregnancy test

Premenstrual Dysphoric Disorder - New drug application submitted to FDA for lower-dose Yasmin

Product Safety - Pharmaceutical distributors face new requirements to reduce counterfeiting

Prostate Cancer - Alternative treatment options available for prostate cancer patients

Prostate Cancer - Black men should be screened for prostate cancer at younger age

Prostate Cancer - Immulite, Immulite 2000 PSA, third-generation PSA assays get CE mark approval

Prostate Cancer - Isonics wins key brachytherapy order

Barrett Esophagus - CPMP positive opinion issued in Europe for Photobarr

Prostate Cancer - Japanese biopharmaceutical company co-promotes prostate cancer treatment

R&D Equipment - New instruments delivered to genomics company

RNA Research - siSTABLE siRNA launched with increased stability, extended silencing

Radiation Therapy - Companies to collaborate on intensity-modulated radiation therapy

Regulatory Issues - FDA completes inspection of manufacturing facility for oral diagnostics company

Renal Cancer - Positive results confirmed for tumor targeted superantigens cancer product

Sepsis - Agreement signed for preclinical testing of gene-silencing antibacterial agent

Solid Tumors - European patent granted for phospholipid vascular targeting agent program

Sterile Aerosol Saline - Drug delivery company enters U.S. eye care market

Thrombocythemia - Agrylin licensed in Japan for treatment of thrombocythemia

Bile Duct Tumors - Investigational new drug application filed for XL119

Tissue Processing - Company licenses novel technology for microorganism inactivation

Trends - Report forecasts 17% annual growth in peripheral vascular stent market

Trends - Study: Noninvasive technologies poised for dramatic growth